Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Matthews

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|September 23, 2019
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trialDavid R Matthews, Päivi M Paldánius, Pieter Proot, et al.
Clinical Endocrinology|March 1, 2003
The regulation of growth in glycogen storage disease type 1Helen R Mundy, Peter C Hindmarsh, David R Matthews, et al.
Public Health Nutrition|September 22, 2012
Physical activity patterns and correlates among adults from a developing country: the Sri Lanka Diabetes and Cardiovascular StudyPrasad Katulanda, Ranil Jayawardena, Ranil Jayawardana, et al.
Diabetes, Obesity & Metabolism|October 23, 2019
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysisIoannis Avgerinos, Theodoros Michailidis, Aris Liakos, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 18, 2014
The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national surveyPrasad Katulanda, Priyanga Ranasinghe, Ranil Jayawardena, et al.
Diabetologia|May 17, 2022
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysisThomas Karagiannis, Ioannis Avgerinos, Aris Liakos, et al.
The New England Journal of Medicine|September 12, 2008
10-year follow-up of intensive glucose control in type 2 diabetesRury R Holman, Sanjoy K Paul, M Angelyn Bethel, et al.
The New England Journal of Medicine|September 12, 2008
Long-term follow-up after tight control of blood pressure in type 2 diabetesRury R Holman, Sanjoy K Paul, M Angelyn Bethel, et al.
Diabetology & Metabolic Syndrome|May 31, 2012
The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing countryPrasad Katulanda, Priyanga Ranasinghe, Ranil Jayawardena, et al.
Clinical Endocrinology|July 19, 2012
Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapyCatherine J Peters, Nathan Hill, Mehul T Dattani, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|September 23, 2019
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trialDavid R Matthews, Päivi M Paldánius, Pieter Proot, et al.
Clinical Endocrinology|March 1, 2003
The regulation of growth in glycogen storage disease type 1Helen R Mundy, Peter C Hindmarsh, David R Matthews, et al.
Public Health Nutrition|September 22, 2012
Physical activity patterns and correlates among adults from a developing country: the Sri Lanka Diabetes and Cardiovascular StudyPrasad Katulanda, Ranil Jayawardena, Ranil Jayawardana, et al.
Diabetes, Obesity & Metabolism|October 23, 2019
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysisIoannis Avgerinos, Theodoros Michailidis, Aris Liakos, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 18, 2014
The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national surveyPrasad Katulanda, Priyanga Ranasinghe, Ranil Jayawardena, et al.
Diabetologia|May 17, 2022
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysisThomas Karagiannis, Ioannis Avgerinos, Aris Liakos, et al.
The New England Journal of Medicine|September 12, 2008
10-year follow-up of intensive glucose control in type 2 diabetesRury R Holman, Sanjoy K Paul, M Angelyn Bethel, et al.
The New England Journal of Medicine|September 12, 2008
Long-term follow-up after tight control of blood pressure in type 2 diabetesRury R Holman, Sanjoy K Paul, M Angelyn Bethel, et al.
Diabetology & Metabolic Syndrome|May 31, 2012
The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing countryPrasad Katulanda, Priyanga Ranasinghe, Ranil Jayawardena, et al.
Clinical Endocrinology|July 19, 2012
Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapyCatherine J Peters, Nathan Hill, Mehul T Dattani, et al.
Pageof 12